Glen Eagle Advisors, LLC Cybin Inc. Transaction History
Glen Eagle Advisors, LLC
- $546 Billion
- Q2 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Cybin Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 1,095 shares of CYBN stock, worth $10,884. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,095Holding current value
$10,884% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CYBN
# of Institutions
63Shares Held
266MCall Options Held
0Put Options Held
0-
Deep Track Capital, LP Greenwich, CT58.1MShares$578 Million0.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA44MShares$437 Million0.18% of portfolio
-
Logos Global Management LP San Francisco, CA40MShares$398 Million1.01% of portfolio
-
Avidity Partners Management LP Dallas, TX34.9MShares$347 Million0.46% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L325.6MShares$254 Million1.01% of portfolio
About CYBIN INC.
- Ticker CYBN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 166,120,000
- Market Cap $1.65B
- Description
- Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...